Announcements

PrEP and Ireland: Availability, Effectiveness, and Concerns

2021-03-12
uc?id=1mHpFm_MrhdFVFguCcnqguqYPrdJje26a

DID YOU KNOW? PrEP is an antiretroviral medication that is safe and well-tolerated; the most common side effect being gastrointestinal that resolves after a few weeks. PrEP can be used by HIV-negative individuals, reducing the risk of HIV infection by 44-92%! It is mainly taken by men who have sex with men (MSM), those with HIV-positive partner, those who engage in risky sexual behaviour, and are intravenous drug users. However, in Ireland, awareness about PrEP is low and there is an issue with non-adherence to the medication.

Read our feature article by Thomas Ragonetti for more information! 
https://www.tsmj.ie/index.php/tsmj/article/view/1734

Read more about PrEP and Ireland: Availability, Effectiveness, and Concerns

Welcome to the TSMJ website!

We are the longest-running Student Medical Journal in Ireland and are currently celebrating our 20th Anniversary!

If you’re interested in joining the team, email us at tsmj@tcd.ie

Thanks for visiting our page. We are exceptionally grateful to all our sponsors and the School of Medicine for the continued long-term support and encouragement.

We have always and will continue to support our peers and colleagues engaging in research and publication as students – as so would love to direct you towards our student journal colleagues in RCSIsmjUCDsmj and jmsGalway that contribute in great quantity and quality towards student publication, research and academic growth.